Dynamic testing of hypothalamic-pituitary function in abnormalities of ovulation.
A review of 26 unusual patients indicates that a combined luteinizing hormone-releasing hormone (LRH)-clomiphene test in conjunction with an estrogen provocation test not only was helpful in identifying underlying pathophysiology of anovulation but also proved useful in the clinical management of the patients. Dynamic testing per se does not establish a diagnosis but, in conjunction with history and other laboratory findings, it does make possible further subdivisions of groups of patients who otherwise appear similar, both clinically and from routine laboratory evaluations. It, therefore, tends to pinpoint a lesion and establish the area in which further tests should be made. It is concluded that the value of such investigations will be more evident as gynecologic endocrinology moves into investigation of the supratentorial control of hypothalamic function and as hypothalamic LRH becomes available as a therapeutic agent.
D000568:Amenorrhea / Q000209:etiology / Q000503:physiopathology; D000858:Anovulation / Q000503:physiopathology*; D002996:Clomiphene; D004958:Estradiol; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000502:physiology; D006801:Humans; D007006:Hypogonadism / Q000150:complications / Q000503:physiopathology; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D010911:Pituitary Neoplasms / Q000150:complications / Q000503:physiopathology; D012658:Sella Turcica; D012888:Skull Neoplasms / Q000150:complications / Q000503:physiopathology
D002996:Clomiphene; D007987:Gonadotropin-Releasing Hormone; D004958:Estradiol